Back to Show
PBS News Hour
What’s keeping biosimilar drugs from the U.S. market?
NewsHour looks at a revolutionary class of drugs called "biologics." Americans have been paying more for their benefits than patients in Europe or Asia some say, because the "generic" versions or "biosimilars" have not hit the U.S. market. Dr. Emily Senay looks into why there's a delay and when American consumers can expect discounts.
Support Provided By
57:46
October 9, 2025 - PBS News Hour full episode
57:46
October 8, 2025 - PBS News Hour full episode
57:46
October 7, 2025 - PBS News Hour full episode
56:45
October 6, 2025 - PBS News Hour full episode
26:45
October 5, 2025 - PBS News Weekend full episode
26:45
August 31, 2025 - PBS News Weekend full episode
26:45
April 5, 2025 - PBS News Weekend full episode
26:44
January 12, 2025 - PBS News Weekend full episode
26:45
January 11, 2025 - PBS News Weekend full episode
57:46
Israel's Prime Minister says the intense phase of the war in Gaza will end soon as Israel and the U.S. argue over weapons deliveries.
57:46
After Claudia Sheinbaum becomes the first woman to win Mexico's presidential election, a look at what that means for U.S. relations.
26:44
"PBS NewsHour" asks NATO’s Secretary General if the delayed U.S. aid to Ukraine is too late to make a difference.